Overcoming barriers to adult immunization

Journal of the American Osteopathic Association

Volumn 109, Issue 6 SUPPL. 2, 2009, Pages

  High, Kevin P ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; VARICELLA ZOSTER VACCINE;

CONFERENCE PAPER; DRUG COST; DRUG EFFICACY; DRUG MARKETING; ETHNICITY; GROUPS BY AGE; HEALTH CARE PERSONNEL; HEALTH SERVICE; HEALTH SURVEY; HERPES ZOSTER; HUMAN; IMMUNIZATION; MEDICARE; PHARMACY; PHYSICIAN; POSTHERPETIC NEURALGIA; REIMBURSEMENT;

ADULT; AGED; HEALTH SERVICES ACCESSIBILITY; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; INCIDENCE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 67650484352     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Oxman MN. Herpes zoster pathogenesis and T cell-mediated immunity and immunosenescence. J Am Osteopath Assoc. 2009;109(suppl 2):S13-S17.
2. Gelb LD. Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination. J Am Osteopath Assoc. 2009;109(suppl 2):S18-S21.
3. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-2284. Available at: http: //content.nejm.org/cgi/content/full/352/22/2271. Accessed April 8, 2009.
4. New data show unacceptably low adult immunization rates and that adults unaware of infectious disease threat [news release]. Washington, DC: National Foundation for Infectious Diseases; January 23, 2008. Available at: http://www.nfid.org /pdf/pressconfs/release-1-23-08.pdf. Accessed April 10, 2009.
5. Hurley LP, Harpaz R, Daley MF, Crane LA, Beaty BL, Barrow J, et al. National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. J Infect Dis. 2008;197(suppl 2):S216-S223. (Pubitemid 351590174)
6. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008;121(7 suppl 2):S28-S35.
7. Centers for Disease Control and Prevention (CDC). Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations- United States, 1996. MMWR Morb Mortal Wkly Rep. 1999;48:886-890. Available at: http: //www.cdc.gov/mmwr/preview/mmwrhtml/mm4839 a4.htm. Accessed April 8, 2009.
8. Straits-Tröster KA, Kahwati LC, Kinsinger LS, Orelien J, Burdick MB, Yevich SJ. Racial/ethnic differences in influenza vaccination in the Veterans Affairs Healthcare System [published online ahead of print September 25, 2006]. Am J Prev Med. 2006; 31:375-382.
9. Centers for Disease Control and Prevention (CDC). Adult immunization: knowledge, attitudes, and practices-DeKalb and Fulton Counties, Georgia, 1988. MMWR Morb Mortal Wkly Rep. 1988;37:657-661.
10. Table 87. Influenza vaccination among adults 18 years of age and over, by selected characteristics: United States, selected years 1989-2006. Health, United States, 2008, With Special Feature on the Health of Young Adults. Hyattsville, Md: National Center for Health Statistics Health; 2008. Available at: http://www.cdc.gov/nchs/data/hus/hus08.pdf #087. Accessed April 9, 2009.
11. Stinchfield PK. Practice-proven interventions to increase vaccination rates and broaden the immunization season [review]. Am J Med. 2008;121 (7 suppl 2):S11-S21. (Pubitemid 351876194)
12. McKibben LJ, Stange PV, Sneller VP, Strikas RA, Rodewald LE; Advisory Committee on Immunization Practices. Use of standing orders programs to increase adult vaccination rates [review]. MMWR Recomm Rep. 2000 Mar 24;49(RR-1):15-16. Available at: http://www.cdc.gov/mmwr/preview /mmwrhtml/rr4901a2.htm. Accessed April 9, 2009.
13. CDC. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. April 4, 1997;46(RR-8):1-24. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/000 47135.htm. Accessed April 9, 2009.
14. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, et al; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. July 13, 2007;56(RR-6):1-54. Available at http://www.cdc.gov/mmwr/preview /mmwrhtml/rr5606a1.htm. Accessed April 9, 2009.
15. Nichol KL. Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults. Am J Med. 1998;105:385-392. (Pubitemid 28536223)
16. Komara FA. Herpes zoster vaccination: benefits and barriers. J Am Osteopath Assoc. 2009;109 (suppl 2):S22-S24.
17. Herpes zoster vaccine Q&A (shingles). Centers for Disease Control and Prevention Web site. Available at: http://www.cdc.gov/vaccines/vpdvac/ shingles/vac-faqs.htm. Accessed April 29, 2009.
18. Fekete T. A varicella-zoster virus vaccine reduced the burden of illness of herpes zoster in older adults. ACP J Club. 2005;143:61. (Pubitemid 41819324)
19. Kerzner B, Murray AV, Cheng E, Ifle R, Harvey PR, Tomlinson M, et al. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older. J Am Geriatr Soc. 2007;55:1499-1507. (Pubitemid 47508516)
20. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published corrections appear in MMWR Morb Mortal Wkly Rep. 2006;55:1303; MMWR Morb Mortal Wkly Rep. 2007;56:256; Pediatrics. 2007;11: 1008]. MMWR Recomm Rep. December 1, 2006; 55(RR- 15):1-48. Available at: http: //www.cdc.gov/mmwR /PDF/rr/rr5515.pdf. Accessed April 29, 2009.
21. Macintyre R, Egerton T, McCaughey M, et al. Concomitant administration of zoster and pneumococcal vaccines in adults <60 years old. Abstract presented at: 48th Annual ICAAC/IDSA 46th Annual Meeting; Washington, DC; 2008. #G-399d.
22. Data sheet: Zostavax. Whithouse Station, NJ: Merck & Co, Inc; February 2009. Available at: http://www.medsafe.govt.nz/profs/datasheet/z/zosta vaxinj.htm. Accessed April 29, 2009.
23. Notice to Readers: Supply of Vaccines Containing Varicella-Zoster Virus. MMWR Morb Mortal Wkly Rep. 2007;56:146-147. Available at: http: //www.cdc.gov/mmwr/preview/mmwrhtml/mm5607 a4.htm.